6.
Wang X, Liao X, Huang K, Zeng X, Liu Z, Zhou X
. Clustered microRNAs hsa-miR-221-3p/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma. J Cancer. 2019; 10(11):2520-2533.
PMC: 6584338.
DOI: 10.7150/jca.29207.
View
7.
Thompson M, Ramsay R
. Myb: an old oncoprotein with new roles. Bioessays. 1995; 17(4):341-50.
DOI: 10.1002/bies.950170410.
View
8.
Odabas G, Cetin M, Turhal S, Baloglu H, Sayan A, Yagci T
. Plexin C1 Marks Liver Cancer Cells with Epithelial Phenotype and Is Overexpressed in Hepatocellular Carcinoma. Can J Gastroenterol Hepatol. 2018; 2018:4040787.
PMC: 6169229.
DOI: 10.1155/2018/4040787.
View
9.
Persson M, Andersson M, Mitani Y, Brandwein-Weber M, Frierson Jr H, Moskaluk C
. Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional Study. Cancers (Basel). 2022; 14(15).
PMC: 9367430.
DOI: 10.3390/cancers14153691.
View
10.
Oura K, Morishita A, Masaki T
. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review. Int J Mol Sci. 2020; 21(21).
PMC: 7664704.
DOI: 10.3390/ijms21218362.
View
11.
Guo Y, Hu J, Zhao Z, Zhong G, Gong J, Cai D
. Identification of a Prognostic Model Based on 2-Gene Signature and Analysis of Corresponding Tumor Microenvironment in Alcohol-Related Hepatocellular Carcinoma. Front Oncol. 2021; 11:719355.
PMC: 8503534.
DOI: 10.3389/fonc.2021.719355.
View
12.
Bolcun-Filas E, Bannister L, Barash A, Schimenti K, Hartford S, Eppig J
. A-MYB (MYBL1) transcription factor is a master regulator of male meiosis. Development. 2011; 138(15):3319-30.
PMC: 3133921.
DOI: 10.1242/dev.067645.
View
13.
Toh T, Lim J, Chow E
. Epigenetics of hepatocellular carcinoma. Clin Transl Med. 2019; 8(1):13.
PMC: 6500786.
DOI: 10.1186/s40169-019-0230-0.
View
14.
Ohta T, Numata M, Tsukioka Y, Futagami F, Kayahara M, Kitagawa H
. Neurotrophin-3 expression in human pancreatic cancers. J Pathol. 1997; 181(4):405-12.
DOI: 10.1002/(SICI)1096-9896(199704)181:4<405::AID-PATH786>3.0.CO;2-3.
View
15.
Yang Q, Liu T, Yang J, Liu F, Chang L, Che G
. Low expression of NTF3 is associated with unfavorable prognosis in hepatocellular carcinoma. Int J Clin Exp Pathol. 2020; 13(9):2280-2288.
PMC: 7539881.
View
16.
Scheau C, Badarau I, Costache R, Caruntu C, Mihai G, Didilescu A
. The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma. Anal Cell Pathol (Amst). 2019; 2019:9423907.
PMC: 6899323.
DOI: 10.1155/2019/9423907.
View
17.
Liao Y, Smyth G, Shi W
. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2013; 30(7):923-30.
DOI: 10.1093/bioinformatics/btt656.
View
18.
Fernandez-Barrena M, Arechederra M, Colyn L, Berasain C, Avila M
. Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg. JHEP Rep. 2020; 2(6):100167.
PMC: 7585149.
DOI: 10.1016/j.jhepr.2020.100167.
View
19.
Das U
. Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review. J Adv Res. 2019; 17:17-29.
PMC: 6526165.
DOI: 10.1016/j.jare.2018.12.006.
View
20.
Ricci A, Greco S, Mariotta S, Felici L, Bronzetti E, Cavazzana A
. Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol. 2001; 25(4):439-46.
DOI: 10.1165/ajrcmb.25.4.4470.
View